1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
644DFA803BB5C7D2500258D3B004B27B1
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/insights/copay-accumulator-pharma-strategies-patient-access?opendocument
18
19opendocument
2018.97.14.90
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25Main






Best Practices, LLC Study Addresses the Challenge of Copay Accumulator Programs: Effective Pharma Strategies for Ensuring Patient Access

CHAPEL HILL, N.C., Nov. 7, 2025/ ---- Across the healthcare landscape, rising out-of-pocket costs are putting essential specialty treatments out of reach for many patients. The growing prevalence of copay accumulator programs has made patient affordability a critical issue for manufacturers and patients alike.

To address this challenge, Best Practices, LLC conducted a comprehensive benchmarking study titled "Meeting the Challenge of Copay Accumulator Programs: Effective Pharma Strategies & Tactics for Ensuring Patient Access." The report examines how specialty pharma manufacturers are mitigating the financial and operational impact of copay accumulator programs while safeguarding patient access and adherence.

The study engaged 25 Market Access and Patient Support executives from 21 specialty biopharma companies, with in-depth interviews from 9 benchmark partners. Insights are segmented into two groups—Total Benchmark Class and Out-of-Pocket (OOP) Costs Minimizers—to showcase differences between average and top-performing manufacturers.

Key Findings Include:

  • Over 54% of manufacturers view copay accumulator programs as a lasting issue with few viable solutions.
  • More than 70% of companies believe current mitigation tactics can be countered by evolving payer strategies, creating an ongoing struggle between payers and pharma.
  • Benchmark partners report increased financial assistance outlays, highlighting the need for smarter, scalable mitigation models.

The full report provides benchmarks and insights around copay accumulator threat assessment, mitigation tactics, financial assistance trends, and KPIs to measure the effectiveness of accumulator response strategies.

Key Topics Covered in the Report Include:

  • Copay accumulator threat assessment and market triggers
  • Effective mitigation strategies and tactics
  • Financial assistance trends and key performance indicators
  • Challenges, lessons learned, and future payer strategies

For a deeper dive, download the complimentary report summary here: https://www.best-in-class.com/rw509.htm

Pressed for time? Watch the accompanying video that summarizes the future threats, payer tactics, and leading mitigation strategies emerging from the study:

 


 

 

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

For Media Inquiries:

Email: psingh@bestpracticesllc.com

Website: https://www.best-in-class.com